인공 장기 및 생체 임플란트 시장 : 유형별, 기술별, 최종사용자별 - 세계 기회 분석 및 산업 예측(2023-2032년)

According to a new report published by Allied Market Research, titled, "Artificial Organs and Bionic Implants Market," The artificial organs and bionic implants market was valued at $44.4 billion in 2022, and is estimated to reach $92.1 billion by 2032, growing at a CAGR of 7.7% from 2023 to 2032.

Bionic implants, on the other hand, are devices that integrate electronic or mechanical components with natural tissues to restore or enhance bodily functions. They are often used to replace or augment sensory organs, such as cochlear implants for hearing loss or retinal implants for vision impairment. Bionic limbs, also known as prosthetics, are artificial limbs that can be controlled by neural signals or muscle contractions to provide mobility and dexterity for individuals with limb loss or limb dysfunction.

Both artificial organs and bionic implants rely on advancements in technology, such as biocompatible materials, sensors, actuators, and control systems, to function effectively. These devices can significantly improve the quality of life for individuals with medical conditions, allowing them to regain lost functionality or compensate for impairments. However, it is important to note that while artificial organs and bionic implants can be highly beneficial, they may not fully replicate the natural functions of the organs they replace and may require ongoing monitoring and maintenance.

Major factors that drive the growth of the global artificial organs and bionic implants market include rapid advancements in artificial organs and bionic implants; an increase in the number of patients suffering from arthritis and blindness and a rise in the number of road accidents and injuries. For instance, according to the data by World Health Organization (WHO), in June 2022, road traffic injury was the leading cause of death among children and young adults aged 5-29 years. As per the same source, approximately 1.3 million people die each year and 20 to 50 million are injured or disabled as a result of road traffic crashes.

However, the high cost associated with implant procedures, and lack of surgical professionals are expected to restrict the growth of artificial organs and the bionic implants market. On the contrary, the surge in healthcare expenditure and unmet medical demands to get better treatment options in developing countries are expected to create lucrative opportunities for the expansion of the global market in the future.

The global artificial organs and bionic implants market is segmented on the basis of type, technology, end-user, and region. On the basis of type, the market is classified into orthopedic bionics, ear bionics, and others. The orthopedic bionics segment is further bifurcated into the bionic hand, bionic leg, and others (bionic limb, bionic finger, bone growth stimulators). Depending on technology, it is bifurcated into electronic and mechanical. By end user, it is segregated into hospitals, ambulatory surgical centers, and others. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

The major players profiled in the report are Abbott Laboratories, Berlin Heart GmbH, Boston Scientific Corporation, Cochlear Limited, Edward Lifesciences Corporations, Jarvik Heart, Inc., Johnson & Johnson, Medtronic plc, SynCardia Systems, LLC, and Zimmer Biomet Holding Inc. These major players have adopted product approval, agreement, acquisition, and product launch as key developmental strategies to improve the product portfolio of the artificial organs and bionic implants market.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the artificial organs and bionic implants market analysis from 2022 to 2032 to identify the prevailing artificial organs and bionic implants market opportunities.
• Market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
• An in-depth analysis of the artificial organs and bionic implants market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes analysis of the regional as well as global artificial organs and bionic implants market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

• Ear Bionics
• Others
• Orthopedic Bionics
  • Orthopedic Bionics Type
  • Bionic Hand
  • Bionic Leg
  • Others

By Technology

• Electronic
• Mechanical

By End User

• Hospitals
• Ambulatory surgical Centers
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players:

• Abbott Laboratories
• Berlin Heart GmbH
• Boston Scientific Corporation
• Cochlear Limited
• Edwards Lifesciences Corporation
• Jarvik Heart, Inc.
• Johnson & Johnson
• Medtronic plc
• SynCardia Systems LLC
• Zimmer Biomet Holding Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key market segments
• 1.3. Key benefits to the stakeholders
• 1.4. Research Methodology
  • 1.4.1. Primary research
  • 1.4.2. Secondary research
  • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
  • 3.2.1. Top impacting factors
  • 3.2.2. Top investment pockets
• 3.3. Porter's five forces analysis
  • 3.3.1. Bargaining power of suppliers
  • 3.3.2. Bargaining power of buyers
  • 3.3.3. Threat of substitutes
  • 3.3.4. Threat of new entrants
  • 3.3.5. Intensity of rivalry
• 3.4. Market dynamics
  • 3.4.1. Drivers
    • 3.4.1.1. Rise in prevalence of cardiac diseases
    • 3.4.1.2. Rise in incidence of trauma and accidents

• 3.4.2. Restraints
  • 3.4.2.1. High cost associated with implant procedure

• 3.4.3. Opportunities
  • 3.4.3.1. Rise in adoption of key strategies

• 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE

• 4.1. Overview
  • 4.1.1. Market size and forecast
• 4.2. Orthopedic Bionics
  • 4.2.1. Key market trends, growth factors and opportunities
  • 4.2.2. Market size and forecast, by region
  • 4.2.3. Market share analysis by country
  • 4.2.4. Orthopedic Bionics Artificial Organs and Bionic Implants Market by Orthopedic Bionics Type
• 4.3. Ear Bionics
  • 4.3.1. Key market trends, growth factors and opportunities
  • 4.3.2. Market size and forecast, by region
  • 4.3.3. Market share analysis by country
• 4.4. Others
  • 4.4.1. Key market trends, growth factors and opportunities
  • 4.4.2. Market size and forecast, by region
  • 4.4.3. Market share analysis by country

CHAPTER 5: ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY

• 5.1. Overview
  • 5.1.1. Market size and forecast
• 5.2. Electronic
  • 5.2.1. Key market trends, growth factors and opportunities
  • 5.2.2. Market size and forecast, by region
  • 5.2.3. Market share analysis by country
• 5.3. Mechanical
  • 5.3.1. Key market trends, growth factors and opportunities
  • 5.3.2. Market size and forecast, by region
  • 5.3.3. Market share analysis by country

CHAPTER 6: ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER

• 6.1. Overview
  • 6.1.1. Market size and forecast
• 6.2. Hospitals
  • 6.2.1. Key market trends, growth factors and opportunities
  • 6.2.2. Market size and forecast, by region
  • 6.2.3. Market share analysis by country
• 6.3. Ambulatory surgical Centers
  • 6.3.1. Key market trends, growth factors and opportunities
  • 6.3.2. Market size and forecast, by region
  • 6.3.3. Market share analysis by country
• 6.4. Others
  • 6.4.1. Key market trends, growth factors and opportunities
  • 6.4.2. Market size and forecast, by region
  • 6.4.3. Market share analysis by country

CHAPTER 7: ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY REGION

• 7.1. Overview
  • 7.1.1. Market size and forecast By Region
• 7.2. North America
  • 7.2.1. Key trends and opportunities
  • 7.2.2. Market size and forecast, by Type
  • 7.2.3. Market size and forecast, by Technology
  • 7.2.4. Market size and forecast, by End User
  • 7.2.5. Market size and forecast, by country
    • 7.2.5.1. U.S.
    • 7.2.5.1.1. Key market trends, growth factors and opportunities
    • 7.2.5.1.2. Market size and forecast, by Type
    • 7.2.5.1.3. Market size and forecast, by Technology
    • 7.2.5.1.4. Market size and forecast, by End User
    • 7.2.5.2. Canada
    • 7.2.5.2.1. Key market trends, growth factors and opportunities
    • 7.2.5.2.2. Market size and forecast, by Type
    • 7.2.5.2.3. Market size and forecast, by Technology
    • 7.2.5.2.4. Market size and forecast, by End User
    • 7.2.5.3. Mexico
    • 7.2.5.3.1. Key market trends, growth factors and opportunities
    • 7.2.5.3.2. Market size and forecast, by Type
    • 7.2.5.3.3. Market size and forecast, by Technology
    • 7.2.5.3.4. Market size and forecast, by End User
• 7.3. Europe
  • 7.3.1. Key trends and opportunities
  • 7.3.2. Market size and forecast, by Type
  • 7.3.3. Market size and forecast, by Technology
  • 7.3.4. Market size and forecast, by End User
  • 7.3.5. Market size and forecast, by country
    • 7.3.5.1. Germany
    • 7.3.5.1.1. Key market trends, growth factors and opportunities
    • 7.3.5.1.2. Market size and forecast, by Type
    • 7.3.5.1.3. Market size and forecast, by Technology
    • 7.3.5.1.4. Market size and forecast, by End User
    • 7.3.5.2. France
    • 7.3.5.2.1. Key market trends, growth factors and opportunities
    • 7.3.5.2.2. Market size and forecast, by Type
    • 7.3.5.2.3. Market size and forecast, by Technology
    • 7.3.5.2.4. Market size and forecast, by End User
    • 7.3.5.3. UK
    • 7.3.5.3.1. Key market trends, growth factors and opportunities
    • 7.3.5.3.2. Market size and forecast, by Type
    • 7.3.5.3.3. Market size and forecast, by Technology
    • 7.3.5.3.4. Market size and forecast, by End User
    • 7.3.5.4. Italy
    • 7.3.5.4.1. Key market trends, growth factors and opportunities
    • 7.3.5.4.2. Market size and forecast, by Type
    • 7.3.5.4.3. Market size and forecast, by Technology
    • 7.3.5.4.4. Market size and forecast, by End User
    • 7.3.5.5. Spain
    • 7.3.5.5.1. Key market trends, growth factors and opportunities
    • 7.3.5.5.2. Market size and forecast, by Type
    • 7.3.5.5.3. Market size and forecast, by Technology
    • 7.3.5.5.4. Market size and forecast, by End User
    • 7.3.5.6. Rest of Europe
    • 7.3.5.6.1. Key market trends, growth factors and opportunities
    • 7.3.5.6.2. Market size and forecast, by Type
    • 7.3.5.6.3. Market size and forecast, by Technology
    • 7.3.5.6.4. Market size and forecast, by End User
• 7.4. Asia-Pacific
  • 7.4.1. Key trends and opportunities
  • 7.4.2. Market size and forecast, by Type
  • 7.4.3. Market size and forecast, by Technology
  • 7.4.4. Market size and forecast, by End User
  • 7.4.5. Market size and forecast, by country
    • 7.4.5.1. Japan
    • 7.4.5.1.1. Key market trends, growth factors and opportunities
    • 7.4.5.1.2. Market size and forecast, by Type
    • 7.4.5.1.3. Market size and forecast, by Technology
    • 7.4.5.1.4. Market size and forecast, by End User
    • 7.4.5.2. China
    • 7.4.5.2.1. Key market trends, growth factors and opportunities
    • 7.4.5.2.2. Market size and forecast, by Type
    • 7.4.5.2.3. Market size and forecast, by Technology
    • 7.4.5.2.4. Market size and forecast, by End User
    • 7.4.5.3. Australia
    • 7.4.5.3.1. Key market trends, growth factors and opportunities
    • 7.4.5.3.2. Market size and forecast, by Type
    • 7.4.5.3.3. Market size and forecast, by Technology
    • 7.4.5.3.4. Market size and forecast, by End User
    • 7.4.5.4. India
    • 7.4.5.4.1. Key market trends, growth factors and opportunities
    • 7.4.5.4.2. Market size and forecast, by Type
    • 7.4.5.4.3. Market size and forecast, by Technology
    • 7.4.5.4.4. Market size and forecast, by End User
    • 7.4.5.5. South Korea
    • 7.4.5.5.1. Key market trends, growth factors and opportunities
    • 7.4.5.5.2. Market size and forecast, by Type
    • 7.4.5.5.3. Market size and forecast, by Technology
    • 7.4.5.5.4. Market size and forecast, by End User
    • 7.4.5.6. Rest of Asia-Pacific
    • 7.4.5.6.1. Key market trends, growth factors and opportunities
    • 7.4.5.6.2. Market size and forecast, by Type
    • 7.4.5.6.3. Market size and forecast, by Technology
    • 7.4.5.6.4. Market size and forecast, by End User
• 7.5. LAMEA
  • 7.5.1. Key trends and opportunities
  • 7.5.2. Market size and forecast, by Type
  • 7.5.3. Market size and forecast, by Technology
  • 7.5.4. Market size and forecast, by End User
  • 7.5.5. Market size and forecast, by country
    • 7.5.5.1. Brazil
    • 7.5.5.1.1. Key market trends, growth factors and opportunities
    • 7.5.5.1.2. Market size and forecast, by Type
    • 7.5.5.1.3. Market size and forecast, by Technology
    • 7.5.5.1.4. Market size and forecast, by End User
    • 7.5.5.2. Saudi Arabia
    • 7.5.5.2.1. Key market trends, growth factors and opportunities
    • 7.5.5.2.2. Market size and forecast, by Type
    • 7.5.5.2.3. Market size and forecast, by Technology
    • 7.5.5.2.4. Market size and forecast, by End User
    • 7.5.5.3. South Africa
    • 7.5.5.3.1. Key market trends, growth factors and opportunities
    • 7.5.5.3.2. Market size and forecast, by Type
    • 7.5.5.3.3. Market size and forecast, by Technology
    • 7.5.5.3.4. Market size and forecast, by End User
    • 7.5.5.4. Rest of LAMEA
    • 7.5.5.4.1. Key market trends, growth factors and opportunities
    • 7.5.5.4.2. Market size and forecast, by Type
    • 7.5.5.4.3. Market size and forecast, by Technology
    • 7.5.5.4.4. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top winning strategies
• 8.3. Product Mapping of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

• 9.1. Berlin Heart GmbH
  • 9.1.1. Company overview
  • 9.1.2. Key Executives
  • 9.1.3. Company snapshot
  • 9.1.4. Operating business segments
  • 9.1.5. Product portfolio
  • 9.1.6. Key strategic moves and developments
• 9.2. Zimmer Biomet Holding Inc.
  • 9.2.1. Company overview
  • 9.2.2. Key Executives
  • 9.2.3. Company snapshot
  • 9.2.4. Operating business segments
  • 9.2.5. Product portfolio
  • 9.2.6. Business performance
  • 9.2.7. Key strategic moves and developments
• 9.3. Boston Scientific Corporation
  • 9.3.1. Company overview
  • 9.3.2. Key Executives
  • 9.3.3. Company snapshot
  • 9.3.4. Operating business segments
  • 9.3.5. Product portfolio
  • 9.3.6. Business performance
• 9.4. Cochlear Limited
  • 9.4.1. Company overview
  • 9.4.2. Key Executives
  • 9.4.3. Company snapshot
  • 9.4.4. Operating business segments
  • 9.4.5. Product portfolio
  • 9.4.6. Business performance
  • 9.4.7. Key strategic moves and developments
• 9.5. Edwards Lifesciences Corporation
  • 9.5.1. Company overview
  • 9.5.2. Key Executives
  • 9.5.3. Company snapshot
  • 9.5.4. Operating business segments
  • 9.5.5. Product portfolio
  • 9.5.6. Business performance
  • 9.5.7. Key strategic moves and developments
• 9.6. Jarvik Heart, Inc.
  • 9.6.1. Company overview
  • 9.6.2. Key Executives
  • 9.6.3. Company snapshot
  • 9.6.4. Operating business segments
  • 9.6.5. Product portfolio
• 9.7. Abbott Laboratories
  • 9.7.1. Company overview
  • 9.7.2. Key Executives
  • 9.7.3. Company snapshot
  • 9.7.4. Operating business segments
  • 9.7.5. Product portfolio
  • 9.7.6. Business performance
  • 9.7.7. Key strategic moves and developments
• 9.8. SynCardia Systems LLC
  • 9.8.1. Company overview
  • 9.8.2. Key Executives
  • 9.8.3. Company snapshot
  • 9.8.4. Operating business segments
  • 9.8.5. Product portfolio
  • 9.8.6. Key strategic moves and developments
• 9.9. Medtronic plc
  • 9.9.1. Company overview
  • 9.9.2. Key Executives
  • 9.9.3. Company snapshot
  • 9.9.4. Operating business segments
  • 9.9.5. Product portfolio
  • 9.9.6. Business performance
• 9.10. Johnson & Johnson
  • 9.10.1. Company overview
  • 9.10.2. Key Executives
  • 9.10.3. Company snapshot
  • 9.10.4. Operating business segments
  • 9.10.5. Product portfolio
  • 9.10.6. Business performance
  • 9.10.7. Key strategic moves and developments